These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24242294)

  • 1. A PNA-mediated clamping PCR for routine detection of KRAS mutations in colorectal carcinoma.
    Messa F; Tonissi F; Millo E; Bracco E; Ungari S; Lattanzio L; Merlano M; Damonte G; Lo Nigro C
    Int J Biol Markers; 2014 Mar; 29(1):e55-61. PubMed ID: 24242294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of KRAS, BRAF, and PIK3CA mutations in advanced colorectal cancers: Comparison of peptide nucleic acid-mediated PCR clamping and direct sequencing in formalin-fixed, paraffin-embedded tissue.
    Kwon MJ; Lee SE; Kang SY; Choi YL
    Pathol Res Pract; 2011 Dec; 207(12):762-8. PubMed ID: 22070922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Companion-diagnostic testing limited to KRAS codons 12 and 13 misses 17% of potentially relevant RAS mutations in colorectal cancer.
    Netzel BC; Grebe SK
    Clin Chim Acta; 2013 Oct; 425():1-2. PubMed ID: 23832066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice.
    Sundström M; Edlund K; Lindell M; Glimelius B; Birgisson H; Micke P; Botling J
    BMC Cancer; 2010 Dec; 10():660. PubMed ID: 21122130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.
    Chang YS; Er TK; Lu HC; Yeh KT; Chang JG
    Clin Chim Acta; 2014 Sep; 436():169-75. PubMed ID: 24863805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer.
    Xu JM; Liu XJ; Ge FJ; Lin L; Wang Y; Sharma MR; Liu ZY; Tommasi S; Paradiso A
    J Exp Clin Cancer Res; 2014 Dec; 33(1):104. PubMed ID: 25491325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRAS gene mutation in a series of unselected colorectal carcinoma patients with prognostic morphological correlations: a pyrosequencing method improved by nested PCR.
    de Macêdo MP; de Melo FM; Lisboa BC; Andrade LD; de Souza Begnami MD; Junior SA; Ribeiro HS; Soares FA; Carraro DM; da Cunha IW
    Exp Mol Pathol; 2015 Jun; 98(3):563-7. PubMed ID: 25835782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer.
    Neumann J; Zeindl-Eberhart E; Kirchner T; Jung A
    Pathol Res Pract; 2009; 205(12):858-62. PubMed ID: 19679400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of PNA clamping and direct sequencing for detecting KRAS mutations in matched tumour tissue, cell block, pleural effusion and serum from patients with malignant pleural effusion.
    Kang JY; Park CK; Yeo CD; Lee HY; Rhee CK; Kim SJ; Kim SC; Kim YK; Park MS; Yim HW
    Respirology; 2015 Jan; 20(1):138-46. PubMed ID: 25302858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.
    Carotenuto P; Roma C; Cozzolino S; Fenizia F; Rachiglio AM; Tatangelo F; Iannaccone A; Baron L; Botti G; Normanno N
    Int J Oncol; 2012 Feb; 40(2):378-84. PubMed ID: 21971641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of low-level KRAS mutations using PNA-mediated asymmetric PCR clamping and melting curve analysis with unlabeled probes.
    Oh JE; Lim HS; An CH; Jeong EG; Han JY; Lee SH; Yoo NJ
    J Mol Diagn; 2010 Jul; 12(4):418-24. PubMed ID: 20413678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens.
    Laosinchai-Wolf W; Ye F; Tran V; Yang Z; White R; Bloom K; Choppa P; Labourier E
    J Clin Pathol; 2011 Jan; 64(1):30-6. PubMed ID: 21030527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High sensitive mutation analysis on KRAS gene using LNA/DNA chimeras as PCR amplification blockers of wild-type alleles.
    Huang Q; Wang GY; Huang JF; Zhang B; Fu WL
    Mol Cell Probes; 2010 Dec; 24(6):376-80. PubMed ID: 20732413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of KRAS, BRAF, PIK3CA and EGFR gene mutations in colorectal carcinoma].
    Ling Y; Ying JM; Qiu T; Shan L; Guo L; Lü N
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):590-4. PubMed ID: 23157825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eprobe-mediated screening system for somatic mutations in the KRAS locus.
    Atsumi J; Hanami T; Enokida Y; Ogawa H; Delobel D; Mitani Y; Kimura Y; Soma T; Tagami M; Takase Y; Ichihara T; Takeyoshi I; Usui K; Hayashizaki Y; Shimizu K
    Oncol Rep; 2015 Jun; 33(6):2719-27. PubMed ID: 25823645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping.
    Beau-Faller M; Legrain M; Voegeli AC; Guérin E; Lavaux T; Ruppert AM; Neuville A; Massard G; Wihlm JM; Quoix E; Oudet P; Gaub MP
    Br J Cancer; 2009 Mar; 100(6):985-92. PubMed ID: 19293811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LNA-based PCR clamping enrichment assay for the identification of KRAS mutations.
    Efrati E; Elkin H; Peerless Y; Sabo E; Ben-Izhak O; Hershkovitz D
    Cancer Biomark; 2010-2011; 8(2):89-94. PubMed ID: 21896996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
    Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer.
    Kuo YB; Chen JS; Fan CW; Li YS; Chan EC
    Clin Chim Acta; 2014 Jun; 433():284-9. PubMed ID: 24685572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of peptide nucleic acid (PNA)-clamp smart amplification process version 2 (SmartAmp2) for clinical diagnosis of KRAS codon 12 mutations in lung adenocarcinoma: comparison of PNA-clamp SmartAmp2 and PCR-related methods.
    Araki T; Shimizu K; Nakamura K; Nakamura T; Mitani Y; Obayashi K; Fujita Y; Kakegawa S; Miyamae Y; Kaira K; Ishidao T; Lezhava A; Hayashizaki Y; Takeyoshi I; Yamamoto K
    J Mol Diagn; 2010 Jan; 12(1):118-24. PubMed ID: 20007840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.